Related Experiment Video
Updated: May 5, 2026

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
Nanoparticle-detained toxins for safe and effective vaccination
Che-Ming J Hu1, Ronnie H Fang, Brian T Luk
11] Department of NanoEngineering and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, USA [2].
A novel nanoparticle strategy safely delivers intact bacterial toxins for vaccination, enhancing antitoxin immunity and protection against toxin-mediated diseases. This approach improves toxoid vaccine efficacy and safety.
Area of Science:
- Immunology
- Vaccine Development
- Nanotechnology
Background:
- Toxoid vaccines, based on inactivated toxins, are crucial for preventing bacterial infections by inducing antitoxin immunity.
- Current methods like heat or chemical denaturation for toxoid vaccines face challenges in balancing antigenic presentation with virulence removal, impacting efficacy and safety.
Purpose of the Study:
- To introduce a nanoparticle-based strategy for delivering non-disrupted pore-forming toxins for enhanced immune processing.
- To evaluate the efficacy and safety of this novel approach compared to traditional toxoid vaccines.
Main Methods:
- Utilizing erythrocyte membrane-coated nanoparticles to encapsulate staphylococcal α-haemolysin.
- Administering nanoparticle-detained toxin to mice for vaccination and assessing protective immunity against toxin-mediated effects.
Main Results:
- Spontaneous entrapment of toxins by nanoparticles led to effective virulence neutralization.
- Mice vaccinated with nanoparticle-detained toxin exhibited superior protective immunity compared to those receiving heat-denatured toxin.
- The non-disruptive detoxification method enhanced both immunogenicity and efficacy of the toxoid vaccine.
Conclusions:
- Nanoparticle-based toxin detainment offers a safe and effective method for developing advanced toxoid vaccines.
- This strategy overcomes the traditional efficacy-safety trade-off, paving the way for new antitoxin vaccines against public health threats.
More Related Videos
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
Related Concept Videos
Vaccinations
Vaccines
Vaccine Production
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...